---  
layout: startup_page  
title: "Diakonos Oncology"  
id: "diakonosoncology.com"  
permalink: "/diakonosoncologydiakonosoncology.com05302025/"  
website: "https://www.diakonosoncology.com"  
funding_round: "SAFE"  
funding_amount: "$20M"  
investors: "Baylor College of Medicine (BCM), Brain Tumor Investment Fund (BTIF), Buttonwood Titan QC Fund, Mike Wicks"  
about: "Diakonos Oncology Corp. is a clinical-stage biotechnology company developing immunotherapies to treat challenging cancers. They focus on their proprietary double-loaded, patient-derived dendritic cell therapeutic platform, particularly with the treatment of late-stage and aggressive cancers. Their lead product, dubodencel (DOC1021), is currently in a Phase 2 glioblastoma trial."  
markets: "Biotech, Oncology, Immunotherapy"  
hq: "Houston, Texas, United States"  
founded_year: "2022"  
linkedin: "https://www.linkedin.com/company/diakonos-oncology"  
twitter: "https://x.com/DiakonosOnc"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/diakonos-oncology"  
pitchbook: "https://pitchbook.com/profiles/company/529306-30"  

date_display: "30-May-2025"  
date: "2025-05-30"

# SEO Optimization  
meta_title: "Diakonos Oncology - SAFE Funding ($20M)"  
meta_description: "Diakonos Oncology, Diakonos Oncology Corp. is a clinical-stage biotechnology company developing immunotherapies to treat challenging cancers. They focus on their proprie..."  
meta_keywords: "Diakonos Oncology, Biotech, Oncology, Immunotherapy, SAFE funding"  
canonical_url: "https://startup.projectstartups.com/diakonosoncologydiakonosoncology.com05302025/"  
---